Moderna, Inc.
mRNA-1010
Seasonal Influenza Vaccine
Date
TBD
FDA decision · Date TBD estimated
What's at stake
The FDA's approval decision on mRNA-1010 for Seasonal Influenza Vaccine is due Date TBD. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“Moderna expects the earliest potential approvals for mRNA-1010 to begin in late 2026 or early 2027, subject to those ongoing regulatory reviews.”